Scarica l'app Stockscreener
4.72
9.23%
-0.48
Dopo l'orario di chiusura:
4.68
-0.04
-0.85%
Precedente Chiudi:
$5.20
Aprire:
$5.29
Volume 24 ore:
70,698
Relative Volume:
0.77
Capitalizzazione di mercato:
$178.53M
Reddito:
$2.76M
Utile/perdita netta:
$-49.12M
Rapporto P/E:
-3.1467
EPS:
-1.5
Flusso di cassa netto:
$-46.21M
1 W Prestazione:
-16.75%
1M Prestazione:
-8.70%
6M Prestazione:
-26.02%
1 anno Prestazione:
-18.34%
Intervallo 1D:
$4.67
$5.3885
Intervallo di 1 settimana:
$4.67
$5.98
Portata 52W:
$3.96
$8.8699
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Confronta OBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.72 | 178.53M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-02 | Iniziato | Barclays | Overweight |
| 2024-08-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | B. Riley Securities | Buy |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2023-02-24 | Iniziato | Piper Sandler | Overweight |
| 2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MyChesCo
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire
Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan
Orchestra BioMed (NASDAQ:OBIO) Shares Up 5.1%Time to Buy? - MarketBeat
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure - MSN
SG Americas Securities LLC Has $51,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading 5.1% Higher – Here’s Why - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Decline in Short Interest - Defense World
How the (OBIO) price action is used to our Advantage - Stock Traders Daily
Individual investors among Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest stockholders and were hit after last week's 11% price drop - Simply Wall St
Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction - Marketscreener.com
Orchestra BioMed Announces Data Demonstrating Favorable - GlobeNewswire
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewswire
Clinical Data: Orchestra BioMed's AVIM Therapy Shows Significant Heart Failure Prevention Benefits | OBIO Stock News - StockTitan
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed Announces Appointment of Former Medtronic - GlobeNewswire
Orchestra BioMed Appoints New Director Amid Board Changes - TipRanks
Christopher Cleary Joins Orchestra BioMed Board of Directors, Enhancing Strategic Leadership in Medical Device Innovations - Nasdaq
Medtronic M&A Veteran Who Led $60B+ in Deals Joins Orchestra BioMed Board - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Barclays PLC Increases Stock Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
When (OBIO) Moves Investors should Listen - Stock Traders Daily
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Jane Street Group LLC - Defense World
(OBIO) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Purchases 11,002 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Barclays PLC Increases Stake in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Simply Wall St
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated by Analysts at Barclays - Defense World
Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead
Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target - MarketWatch
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Barclays - MarketBeat
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model By Investing.com - Investing.com Nigeria
State Street Corp Has $2.21 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra Biomed CEO David Hochman buys $18,640 in common stock By Investing.com - Investing.com Australia
Orchestra Biomed CEO David Hochman buys $18,640 in common stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds - Yahoo Finance
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com Canada
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):